Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Orgenesis Inc ORGS

Orgenesis Inc. is a biotech company focused on cell and gene therapies (CGTs). The Company focuses on the development of autologous therapies that can be manufactured under processes and systems that are developed for each therapy using a closed and automated approach that is validated for compliant production near the patient for treatment of the patient at the point of care. It operates in... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >

Opinion & Analysis (NDAQ:ORGS)

Convergence Will Drive the Ultimate Disruption of Life Sciences

Streetwise Reports March 28, 2018

A new breed of regenerative therapy companies taking hold

Streetwise Reports December 11, 2017

Bullboard Posts (NDAQ:ORGS)

Dakota Gold And 2 Other Stocks Under $3 Insiders Are Buying

JUST IN: $ORGS Dakota Gold And 2 Other Stocks Under $3 Insiders Are Buying | BenzingaThe Dow Jones index closed higher by more than 150...
whytestocks - February 15, 2024

Much going for the future of this company

Two Noble laureates working for this company, Located in Isreal, a leading cutting edge country in different kinds of research. ...
macman1519 - January 27, 2015

High spec high risk huge possible rewards

Interesting concept, trials in a year, upside monumental and with a son with type 1 , i pray they succeed. Not putting  great deal...
macman1519 - January 27, 2015